Accounting Manager, R&D

Location: Palo Alto, CA / Princeton, NJ ONSITE

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

• HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
• HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
• HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

• HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

The Accounting Manager (R&D) will be an integral member of the Accounting team, primarily focused on accounting for the Company’s multiple ongoing and planned clinical trials. You will focus on the preparation of monthly journal entries and ensuring completeness and accuracy of the Company’s clinical trial-related expenses. In this role, you will assist in analyzing the monthly clinical trial expenses, working with the clinical operations team and third-party vendors. Attention to detail and adherence to ongoing deadlines will be important for success in this role.

Role and Responsibilities:

• Support the monthly close process to ensure timely and accurate financial reporting, with a focus on continuous process improvement and reducing close timelines
• Prepare and review high visibility CRO entries, Investigator Grant entries, and other R&D entries
• Own/review the accounting and financial tracking for clinical trial accruals, working closely with cross-functional teams to ensure the data is complete, accurate, and audit-compliant
• Lead site payments process with 3rd party vendor clinical sites by reviewing invoices, checking them against Clinical Trial Agreements (CTAs), working with the Clinical Operations team and resolving any issues quickly and timely
• Collaborate cross-functionally with other teams like Clinical Operations, Vendor Management and Legal to support strategic business objectives and ensure the accuracy of financial information